APH vs. AMYT, BMK, AGY, BXP, ANCR, EAH, CEL, DNL, STX, and PXS
Should you be buying Alliance Pharma stock or one of its competitors? The main competitors of Alliance Pharma include Amryt Pharma (AMYT), Benchmark (BMK), Allergy Therapeutics (AGY), Beximco Pharmaceuticals (BXP), Animalcare Group (ANCR), ECO Animal Health Group (EAH), Celadon Pharmaceuticals (CEL), Diurnal Group (DNL), Shield Therapeutics (STX), and Provexis (PXS). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Amryt Pharma (LON:AMYT) and Alliance Pharma (LON:APH) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment, earnings and community ranking.
Amryt Pharma has a net margin of 0.00% compared to Amryt Pharma's net margin of -4.15%. Alliance Pharma's return on equity of 0.00% beat Amryt Pharma's return on equity.
Alliance Pharma has a consensus target price of GBX 56.50, suggesting a potential upside of 45.62%.
68.3% of Alliance Pharma shares are owned by institutional investors. 11.8% of Alliance Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
In the previous week, Alliance Pharma's average media sentiment score of 0.00 equaled Amryt Pharma'saverage media sentiment score.
Amryt Pharma has higher revenue and earnings than Alliance Pharma. Alliance Pharma is trading at a lower price-to-earnings ratio than Amryt Pharma, indicating that it is currently the more affordable of the two stocks.
Amryt Pharma received 40 more outperform votes than Alliance Pharma when rated by MarketBeat users. Likewise, 65.68% of users gave Amryt Pharma an outperform vote while only 62.08% of users gave Alliance Pharma an outperform vote.
Summary
Amryt Pharma beats Alliance Pharma on 6 of the 11 factors compared between the two stocks.
Get Alliance Pharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for APH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding APH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alliance Pharma Competitors List
Related Companies and Tools
